EDITION OF SAT 21 NOV 2026
308 · U.S.

White House Withdraws Heidi Overton’s Nomination to Lead FDA

publishers 21articles 22first reported 17 Nov, 14:45 UTCdeveloping since 18 Nov · 5 editions

The White House has withdrawn President Donald Trump’s nomination of Dr. Heidi Overton to lead the Food and Drug Administration, a White House official told The Guardian, ending a confirmation bid that had struggled to secure enough Republican support.

The Senate Health, Education, Labor and Pensions Committee had been scheduled to vote on Overton’s nomination Wednesday. CBS News reported before the withdrawal that no committee Democrats were expected to support her and that several Republicans had not committed to advancing the nomination. The White House had begun speaking with possible replacements, including candidates who could serve in an acting capacity, according to CBS News.

Overton faced scrutiny from Republicans with differing positions on abortion access. Sen. Josh Hawley of Missouri questioned how she would handle a promised safety study of mifepristone, while Sens. Susan Collins of Maine and Lisa Murkowski of Alaska had not announced how they would vote. Anti-abortion group Susan B. Anthony Pro-Life America had urged the Senate to delay confirmation and sought restrictions on mifepristone distribution.

The Guardian also reported that committee chair Sen. Bill Cassidy of Louisiana remained undecided and had challenged Overton over her support for Trump’s proposal to separate combination childhood vaccines, as well as her willingness to act independently of the administration. Reproductive Freedom for All welcomed the withdrawal, citing concerns about medication abortion access.

HOW THIS STORY WAS MADE

Written from 4 articles, 2 with the publisher's own text; 3 independent newsrooms once syndicated copies count as one; this version written 12 h after the record first saw the story; the editor kept it as written.

Publishers
21
Source articles
22
Given to the writer
4, 2 with the article's own text
Independent newsrooms
3
This version written
12 h after the record first saw the story
Second model (editor)
kept as written
Publication gate
passed
Human review
none

WHAT THE EDITOR DID

The second model checked the writer's draft against the same sources and published it as written.

Written by a language model from the sources above, then checked by a second model that may only cut, attribute or correct. How it works →

NAMED IN THE COVERAGE

OUTLETS CARRYING THE STORY, RUN BY RUN

0 10 21 19 Nov 20 Nov 21 Nov 22 Nov 18 Nov 12:23 UTC · White House Withdraws Heidi Overton’s Nomination to Lead FDA

WHAT HELD, WHAT CAME LATER

From the first reports to the latest

  • Nothing ran from the first third of the coverage to the last.

Entered the story later

  • Nothing new took hold after the first third.

HOW THIS STORY DEVELOPED: EVERY HEADLINE, EVERY OUTLET →